SCHEMBL4631009

SCHEMBL4631009

CC1(C)CCCN(c2cccc(Oc3ccc(N)cc3)c2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
MAPT P10636 2/20 0.47
MITF O75030 1/20 0.47
GAA P10253 1/20 0.47
GFER P55789 1/20 0.47
NLRP1 Q9C000 1/20 0.47
NOD2 Q9HC29 1/20 0.47
LTA4H P09960 1/20 0.41
MAOB P27338 1/20 0.40
CYP3A4 P08684 5/20 0.39
USP2 O75604 4/20 0.39
TSHR P16473 3/20 0.39
MAOA P21397 1/20 0.39
PARP14 Q460N5 2/20 0.39
PARP10 Q53GL7 2/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4630975 0.85 PARP10 (0.55) ALDH1A1MEN1KMT2ACYP3A4USP2
SCHEMBL4630330 0.81 ALDH1A1 (0.59) ALDH1A1MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL6606547 0.79 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL27405147 0.74 NOTUM (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2CYP3A4
SCHEMBL16621272 0.72 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL27409032 0.71 PRMT6 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2CYP3A4
SCHEMBL4347686 0.70 ALDH1A1 (0.51) ALDH1A1MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL11510734 0.69 SLC6A2 (0.52) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL22465998 0.69 MAPT (0.50) ALDH1A1MEN1KMT2ASMN1; SMN2MAPT
SCHEMBL29366093 0.68 ALDH1A1 (0.83) ALDH1A1MEN1KMT2ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed